New Perspectives on Antimicrobial Agents: Rezafungin
Antimicrobial Agents and Chemotherapy · 31.01.2025 · 69 (1)
DOI: 10.1128/aac.00646-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 31.01.2025. Verfasst von Nicholas M Forrister und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Echinocandins, Antifungal Agents, Candidiasis, Invasive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candidemia and invasive candidiasis persist as significant causes of morbidity and mortality. As fluconazole resistance rates rise, alternative means of treatment are necessary, either via mold-active azoles or extended durations of echinocandins. These come with the potential for undesirable side effects for triazoles or choosing between prolonged hospitalization or outpatient parenteral antimicrobial therapy in the case of echinocandins. Rezafungin offers an opportunity to manage extended treatment durations with shorter hospital stays and no extended parenteral access. Herein, we review the most recent published data pertaining to rezafungin including anti-fungal activity, pharmacokinetics, and clinical data relating to the treatment of invasive candidiasis. Given its prolonged half-life allowing for once-weekly dosing, rezafungin has the potential as an anti-fungal prophylactic agent in high-risk patients, and studies to examine this potential role are ongoing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.
ORCID-Profile: Peter G Pappas
Zitieren
APA
Forrister, N. M., McCarty, T. P., & Pappas, P. G. (2025). New Perspectives on Antimicrobial Agents: Rezafungin. Antimicrobial Agents and Chemotherapy, 69(1). https://doi.org/10.1128/aac.00646-23
Vancouver
Forrister NM, McCarty TP, Pappas PG. New Perspectives on Antimicrobial Agents: Rezafungin. Antimicrobial Agents and Chemotherapy. 2025;69(1). doi:10.1128/aac.00646-23
BibTeX
@article{Forrister2025,
author = {Forrister, Nicholas M and McCarty, Todd P and Pappas, Peter G},
title = {New Perspectives on Antimicrobial Agents: Rezafungin},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {1},
doi = {10.1128/aac.00646-23}
}
EUVIMED